Who We Are

We believe in automating the process of continuous decision making and intelligence generation.

Herbert A. Simon coined the phrase “bounded rationality” to express the idea that human decision-making is limited by available information, available time and the mind’s information-processing ability. In today’s world although the information is readily available, the decision making is getting increasingly limited by human mind’s ability to process ever increasing volume of information. Any process which increases the signal to noise ratio in information will help in faster decision making by reducing the net amount of information that mind eventually needs to process.

In 2011, we looked at the decision making landscape in organizations and observed that the available technologies and paradigms were helping make decisions but with fixed cycles of information processing, running in batches, with little flexibility and agility. We saw products sacrificing usability for more features, deployment times of months and requiring days and weeks of training to get started.

We saw a gap between the consulting and technology paradigms and sensed the need of a different paradigm. That is when we founded Innoplexus.

Supervisory Board

  • Hans-Christian Semmler
    Hans-Christian Semmler Chairman, Supervisory Board

    Hans-Christian Semmler is Managing Director of Frankfurt based, technology focused, HCS Beteiligungsgesellschaft mbH, founded in 2003. Since 2014, he is also a member of the supervisory board of AGO AG Energie + Anlagen.

    From 2003 to 2010, he held the position of CEO at Haupt Pharma AG, a contract manufacturer and developer of pharmaceutical products with various company sites in Europe and Japan. From 1995 to 2001, he was CFO of Vossloh AG, one of the world’s leading railway engineering companies. He was also a member of the supervisory board of VAE AG. Prior to this, he worked in investment banking in Deutsche Bank.

    Hans-Christian Semmler studied law and business administration in Kiel, Vienna and Passau and is authorized to practice as a lawyer.

  • Florian Rentsch
    Florian Rentsch Deputy Chairman, Supervisory Board

    Florian Rentsch is an advisory member of the Broich Partnerschaft von Anwälten mbB with a focus on strategic counseling in business law, governance, compliance and labor law.

    Florian Rentsch advises German and international clients in the fields of transactions, corporate governance and high level compliance as well as in special employment situations. Florian Rentsch has many years of practical expertise in the areas of finance, pharmaceuticals, health, chemicals, transport and energy.

    From 2012 to 2014 he was Minister of State at the Ministry of Commerce, Transport and Regional Development in the German state of Hessen.

    Florian Rentsch studied law in Mainz and Frankfurt am Main and is authorized to practice as a lawyer.

  • Prof. Dr. Werner Gleißner
    Prof. Dr. Werner Gleißner Member, Supervisory Board

    Prof. Werner Gleißner is a member of the Executive Board of FutureValue Group AG, a research and development-oriented company consulting company with a focus on value-oriented, strategic management and risk management.

    Since 1990, Dr. Gleißner has been the managing partner of WIMA GmbH, a consulting company and a member of BDU. As founder, he was also CEO of RMCE RiskCon GmbH, a consulting company with a focus on risk management from 2000 to 2007, and from 2008 to 2011 he was responsible for the risk research at Marsh GmbH.

    Dr. Gleißner focusses on risk management, rating and strategy development as well as the further development of methods for simulations-based risk aggregation.

    Since obtaining his PhD in economics (thesis on monetary policy, econometrics and theory of action), he has been a lecturer and since 2014 an honorary professor at the TU Dresden.

Leadership Team

  • Dr. Gunjan Bhardwaj
    Dr. Gunjan Bhardwaj Founder and CEO

    Gunjan Bhardwaj is the Founder and CEO of the Innoplexus group. He was earlier with the Boston Consulting Group and before that the leader of the global business performance think-tank of Ernst & Young and a manager in the German practice with a solution focus on strategy and innovation.

    He has led projects in strategy, analytics and technology for various clients in different parts of the world. Gunjan was also a partner, senior-editor and advisor for a prominent online innovation management journal and was a member of the scientific advisory board of a US based not for profit institute researching in complexity sciences in the healthcare industry. Gunjan is also a guest lecturer at the European Business School for growth management based out of Frankfurt, Germany and FIA Business School in Sao Paulo. He has also been in the advisory board of a Future management initiative of a big Pharma company in Germany. He was also an honorary representative of the state of Baden-Württemberg to India. Gunjan has been publishing in many scientific and business journals such as the Harvard Business Review, MIT Sloan Review and Journal of Service Research. He has also published a book on marketing in emerging markets.

    He has studied at IIT Bombay, Pforzheim Business School, MIT Sloan and European Business School.

  • Gaurav Tripathi
    Gaurav Tripathi Co-Founder and CTO

    Gaurav is the Co-Founder and CTO of Innoplexus. With a focus on Big Data, Gaurav has more than 12 years of cross-industry expertise and experience across web 2.0, online video, large scale consumer and enterprise infrastructure, public and private cloud services, big data technology and analytics, enterprise security, mobility, IoT, telemetry and social networks.

    He helped build a telematics platform for curbing malpractices in food grains and kerosene distribution in one of the Indian state government’s public distribution system. He has helped large organizations and startups alike in getting an edge on technology and product development and has helped scale digital political campaigns as well during various elections in India. He has been instrumental in forging key partnerships on technology front with world’s leading technology companies.

  • Dr. Jürgen Raths
    Dr. Jürgen Raths MD - Head of Life Sciences

    Jürgen Raths leads the Life sciences division and brings with him over 30 years of professional experience. Prior to joining Innoplexus, Jürgen has held various medical, commercial and general management roles in the pharmaceutical industry in Europe and the USA.

    As Head of Critical Care Europe, he built up the first pan European business unit at Eli Lilly, focused on providing highly specialized clinical customers such as interventional cardiologists and intensive care clinicians with innovative and best in class products, scientific and commercial services.

    ​Jürgen has served as CEO of Swiss public biotech company Arpida and as well as CEO of Correvio, a private Swiss biotech enterprise.

    Jürgen earned his MD from Rheinische Friedrich Wilhelms University Bonn.

  • Holger Hoffmann
    Holger Hoffmann CFO

    Holger Hoffmann is the Chief Financial Officer of Innoplexus. He brings with him over 20 years of broad international experience in Sales, Finance, Controlling, Joint Ventures, M&A, and Operations within management holdings, family-owned companies, and large industrial corporations.

    Holger has the rare combination of experience in finance and sales, and due to his multilingual capability and genuine interest in diverse cultures and has developed excellent global business relationships. During his tenure at Anchor Electricals, India, he was able to increase profits by 326% and sales by 40% while reducing inventory by 42% within Wires & Cables BU in 19 months.

    He has held various positions in Finance, Sales and general management in Europe and Asia. He started his career with Lieutenant, Special forces, Germany Army and progressively moved into the Board member position at Anchor Electricals.

    Holger holds a Master’s degree from Henley College, UK specialized in Business & Finance. He also holds German diploma in Business IT as well as Master’s in International Business Law

  • Lawrence Ganti
    Lawrence Ganti CEO - Innoplexus Americas

    Lawrence Ganti is the Chief Executive Officer at Innoplexus, Americas. Lawrence brings with him over 20 years of experience in healthcare, technology, and consumer goods where he has worked across general management, commercial development, strategy formulation, and marketing. Amongst his many achievements, Lawrence led the post merger integration of Merck and Serono’s international business; implemented a turnaround of Merck’s business in India; spearheaded a transformation of the Latin America operations; and launched an award winning marketing campaign in Japan.

    Prior to joining Innoplexus, he built an impressive career over 14 years with Merck KGaA, where he held various leadership positions across Europe, Asia, and Latin America. Most recently Lawrence held the position of President – Latin America at Merck. He started his career with PepsiCo, Marriott, and Johnson & Johnson, then moved to McKinsey & Company before taking on business development roles for various technology startups.

    Lawrence holds an MBA from IMD In Switzerland and BS in Entrepreneurship from Babson College, USA.

  • Silke Otte
    Silke Otte CMO

    Silke Otte is the Chief Marketing Officer of Innoplexus and brings more than 22 years of IT and financial services industry experience in digital channels, advertising, customer relationship management (CRM), campaign management, and concept development.

    Prior to joining Innoplexus, Silke Otte served as Chief Marketing Officer at paydirekt, where she was involved in the company building and responsible for the development of PR and marketing strategies in cooperation with the German banks and important ecommerce merchants. Before that, Silke served as Director Marketing at Union Investment and Sage. She managed strategic and operational omnichannel brand campaigns, media planning, and online marketing. She commenced her career as an account manager at M-S-B+K Agency for Direct Marketing before moving onto being a Project Manager at Citi.

    Silke holds a master’s degree in Nutritional Science and Household Economics from The University of Kiel.

  • Graeme Mcfarlane
    Graeme Mcfarlane CCO - Chief Commercial Officer

    Graeme Mcfarlane is the Chief Commercial Officer at Innoplexus and has held varied and progressive roles in both the ethical pharmaceutical arena and latterly business to business.  With  over 30 years senior management leadership and commercial experience, he brings with him an in-depth understanding and reach into the healthcare market, together with a proven track record in providing solutions for healthcare clients that are relevant and insightful.

    Prior to joining Innoplexus Graeme Mcfarlane was a senior director with QuintilesIMS having sold his Market Access company to the same in 2013.

    Graeme Mcfarlane holds and MBA from Dundee University.

  • Kumar Anshu
    Kumar Anshu CEO - Innoplexus India

    Kumar Anshu is the Chief Executive Officer at Innoplexus, India and brings with him over 11 years of hands on experience in change management, operational excellence, OD, solution selling, and innovation management. Kumar has served at varied leadership positions at top global IP management & software product firms as well as young B2B /B2C technology start-ups.

    In 2015 , Anshu started an initiative named “Productive Humour” which uses humour based scientific frameworks to help organisations to be more productive, less stressful and more engaged. Kumar is a certified Six Sigma Black Belt from American Society for Quality (ASQ), certified Behavioral Trainer from Oscar Murphy International (Singapore) and a certified Project Management Professional from Project Management Institute (USA).

    Kumar is a B.Tech from IIT Bombay and also completed executive management program in sales and marketing from IIM Lucknow.

Advisory Team of Life Science

  • Alph Bingham
    Alph Bingham

    Alph Bingham is a strong advocate of open innovation and co-founded InnoCentive, Inc., along with co-founding or incubating other ventures that create the advantages of open and networked organizational structures, including: YourEncore, Inc., Coalesix, Inc., Maaguzi, Inc., Indigo Biosystems, Seriosity, Chorus and Collaborative Drug Discovery, Inc. 

    Experience: Founder & Board of Directors Innocentive, Advisory Board Massachusetts Institute of Technology, Center for Collective Intelligence, Adisory Board Business Innovation Factory, Vice President of R&D and Strategy Eli Lilly

  • Glyn Parkin
    Glyn Parkin

    Glyn Parkin is bio-pharmaceutical leader with strategic and p&l experience globally and in individual markets including the USA and the U.K. Deep experience in diabetes/metabolism and in mental health, and also in global strategic alliance formation and leadership. Most recent experience as SVP and Therapeutic Area Head Diabetes and Metabolism, based in Germany with a global remit, leading a cross-functional team of global heads and VPs. Currently CEO and board director at Actimed Therapeutics Ltd, and Chairman of the board at cancer services company HSC Ltd.

    Experience: SVP Therapeautic  Area Diabetes & Metabolic Disorders at Boehringer Ingelheim GmbH, Head of Corporate Marketing Diabetes at Boehringer Ingelheim, MD UK & SVP Int Ops at The Medicines Company, CMO EMEA & Russia/CIS at Eli Lilly, VP and BU Head Neuroscience USA at Lilly, Exec Director and BU Head Diabetes USA at Eli Lilly, Head of Global Diabetes Marketing at Eli Lilly.

  • Prof. Dr. Eberhard Kochs
    Prof. Dr. Eberhard Kochs

    Professor Emeritus of Anesthesiology of the Technical University Munich at the Hospital rechts der Isar. Trained as physicist and physician, Professor Kochs has been Board member and chaired various anaesthesiasocieties amongst them the European Society of Anaesthesiology, being member of many international societies. With hundreds of peer reviewed publications including aspects of machine-patient interactions amongst many others, Professor Kochs has a strong influence as academic teacher and thought leader.

    Experience: Professor Emeritus TUM, Chair Department of Anesthesia TUM, Physicist at the Department of Electrical Engineering at the Technical University Aachen

  • Javier Garcia
    Javier Garcia

    Javier Garcia is an entrepreneur, investor and independent consultant, investor in the field of Biotechnology. Javier had a 25-year career at Eli Lilly and Company where he held executive positions in Business Development and Information Technology.  He lived in the USA for more than 15 years.

    Experience: He is Founder and General Partner of Columbus Venture Partners, a venture capital Fund in the Biotech Sector. He is also the Founder of the Columbus Foundation, a non for profit organization dedicated to promote the access to health technology to children and also focus on the promotion of cultural activities. He is a Trustee for the National Alliance for Hispanic Health and for the Healthy American Foundations, both organizations based in Washington DC. He is a Board Member of Artax Biopharma,  Bioncotech Therapeutics, Vivet Therapeutics ViralGen Vector Core and PTS. Mr. Garcia holds a Bachelor in Mathematics (Statistics and Operations Research) from Universidad Complutense of Madrid and a MBA from ICADE.

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search